Clinical Trial Update: Targeted Indoor Residual Spraying Against Malaria [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on targeted indoor residual spraying for malaria; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Malaria | Phase 4 | Status: COMPLETED